Healthcare provider profile · identity verified

Andrew David Snider, M.D.

Family Practice · ASHLAND, WI · NPI 1659548584

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	121
Losartan Potassium	Losartan Potassium	368	99
Lisinopril	Lisinopril	275	68
Rosuvastatin Calcium	Rosuvastatin Calcium	273	79
Metoprolol Succinate	Metoprolol Succinate	239	58
Pantoprazole Sodium	Pantoprazole Sodium	215	56
Amlodipine Besylate	Amlodipine Besylate	210	55
Metformin Hcl	Metformin Hcl	201	57
Hydrochlorothiazide	Hydrochlorothiazide	200	54
Levothyroxine Sodium	Levothyroxine Sodium	193	54
Trulicity	Dulaglutide	182	29
Omeprazole	Omeprazole	178	49
Furosemide	Furosemide	169	52
Potassium Chloride	Potassium Chloride	148	42
Eliquis	Apixaban	135	24
Tamsulosin Hcl	Tamsulosin Hcl	130	38
Gabapentin	Gabapentin	125	30
Albuterol Sulfate Hfa	Albuterol Sulfate	102	39
Jardiance	Empagliflozin	102	18
Simvastatin	Simvastatin	101	29
Warfarin Sodium	Warfarin Sodium	97	23
Sertraline Hcl	Sertraline Hcl	89	22
Metoprolol Tartrate	Metoprolol Tartrate	88	24
Ozempic	Semaglutide	82	18
Carvedilol	Carvedilol	68	20
Duloxetine Hcl	Duloxetine Hcl	68	19
Trazodone Hcl	Trazodone Hcl	64	16
Metformin Hcl Er	Metformin Hcl	61	16
Allopurinol	Allopurinol	59	17
Atenolol	Atenolol	58	14
Meloxicam	Meloxicam	58	22
Montelukast Sodium	Montelukast Sodium	56	15
Xarelto	Rivaroxaban	54	11
Oxybutynin Chloride Er	Oxybutynin Chloride	52	13
Quetiapine Fumarate	Quetiapine Fumarate	50	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	20
Mounjaro	Tirzepatide	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	17
Ezetimibe	Ezetimibe	46	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	15
Pravastatin Sodium	Pravastatin Sodium	42	12
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Finasteride	Finasteride	37	suppressed
Spiriva Handihaler	Tiotropium Bromide	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	13
Lovastatin	Lovastatin	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Celecoxib	Celecoxib	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Famotidine	Famotidine	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Olanzapine	Olanzapine	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Dilt-Xr	Diltiazem Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Nystatin	Nystatin	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	14
Glimepiride	Glimepiride	21	suppressed
Glipizide	Glipizide	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Valsartan	Valsartan	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	19	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Prednisone	Prednisone	18	14
Sucralfate	Sucralfate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Topiramate	Topiramate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Naproxen	Naproxen	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Diazepam	Diazepam	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error